Founded in 2013, Dijia Pharmaceutical Group Co., Ltd. is a subsidiary of Disha Pharmaceutical Group and a national high-tech enterprise.

According to the requirements of national strategic emerging industries, the company mainly uses new technologies, new processes and new equipment of scientific and technological innovation to produce green and safe raw materials, pharmaceutical intermediates and biological products. According to the action site and mechanism of downstream preparations, the main products cover musculoskeletal system, cardiovascular system, digestive tract and metabolism, respiratory system and nervous system.

The company has Weihai, Tianjin and other technical research institutes. The research center is equipped with advanced detection instruments such as liquid mass spectrometer, inductively coupled plasma mass spectrometer, X-ray powder diffractometer, nuclear magnetic resonance spectrometer, high performance liquid chromatograph, gas chromatograph, Fourier transform infrared spectrophotometer, atomic absorption spectrometer, thermal analyzer, ultraviolet/visible spectrophotometer, Karl's moisture analyzer, as well as high-pressure reactor, Hastelloy alloy condenser and other pilot test equipment.

Advanced instruments and equipment, perfect management system and advanced drug research and development personnel in the industry ensure the company's continuous innovation ability.

The company's products strictly implement international and domestic standards, and the company's production system has passed the quality management system certification of Japan, the European Union and other countries, marking the company's API quality management concept and technical strength to reach the world's advanced level.

The company's API market is expanding to various sales terminals and international markets. The products are now sold to Japan, South Korea, India and other countries and regions, and many leading products have a leading domestic market share.
 

development process

In 2013, Dejia Pharmaceutical Group Co., Ltd. was established in 2015. "Olmesartan Medoxomil" project was awarded Taishan Industry Leading Talents in 2016...

Learn more

Enterprise culture

Company mission: to create value for customers, create a development platform for employees, create contributions to society, and help the cause of human health. Company vision: to become a world-class high-end chemical pharmaceutical company. company strategy: rooted in the pharmaceutical industry, by creating a first-class talent team, the development of the country...

Learn more